KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to -$0.8.

  • Ionis Pharmaceuticals' EPS (Basic) rose 1578.95% to -$0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.61, marking a year-over-year increase of 3401.64%. This contributed to the annual value of -$3.04 for FY2024, which is 1875.48% down from last year.
  • Per Ionis Pharmaceuticals' latest filing, its EPS (Basic) stood at -$0.8 for Q3 2025, which was up 1578.95% from $0.78 recorded in Q2 2025.
  • Ionis Pharmaceuticals' EPS (Basic)'s 5-year high stood at $1.59 during Q4 2021, with a 5-year trough of -$1.03 in Q3 2023.
  • Moreover, its 5-year median value for EPS (Basic) was -$0.6 (2023), whereas its average is -$0.46.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' EPS (Basic) tumbled by 107059.27% in 2024, and later surged by 27252.92% in 2025.
  • Ionis Pharmaceuticals' EPS (Basic) (Quarter) stood at $1.59 in 2021, then tumbled by 123.52% to -$0.37 in 2022, then surged by 83.92% to -$0.06 in 2023, then tumbled by 1070.59% to -$0.7 in 2024, then dropped by 13.9% to -$0.8 in 2025.
  • Its EPS (Basic) stands at -$0.8 for Q3 2025, versus $0.78 for Q2 2025 and -$0.93 for Q1 2025.